Malcolm Wilson

The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester
Consultant Colorectal and Peritoneal Oncology Surgeon

Malcolm has been a Consultant Colorectal and Peritoneal Oncology Surgeon at the Christie Hospital NHS Foundation Trust since 2000. Having been Clinical Director for Surgery, Christie Hospital from 2006-2014 and Lead Clinician for Colorectal Cancer, Christie Hospital from 2016-2018, he has been the Joint Lead of the Peritoneal Tumour Service, Christie Hospital since 2002. Malcolm am a Senior Lecturer at the Dept of Medicine, University of Manchester. His unit was awarded Cancer Care Team of the year at the BMJ Awards in 2013 for its work in the care of patients with colorectal peritoneal metastases.

dont miss

Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours

The aim will be to give an overview in the management of peritoneal disease from both appendiceal and colorectal tumours. This will pay particular attention to the use of cytoreductive surgery and heated intra-peritoneal chemotherapy (HIPEC) and will draw on my unit’s experience of being one of the National Centres in the UK that treats this. We have performed over 1250 cases over the last 18 years and now perform 155-160 cases per year.

EVEN MORE SEMINARS

  • Rae Denman, and Dr Zoe Poole.: Speaking at the Oncology Convention

    Rae Denman, and Dr Zoe Poole.
    The British Association of Medical Tattooing (BAMT)

    Medical Tattooing: Regulating the industry

  • Malcolm Wilson: Speaking at the Oncology Convention

    Malcolm Wilson
    The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester

    Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours

  • Dr Tony Dhillon: Speaking at the Oncology Convention

    Dr Tony Dhillon
    University of Surrey and Royal Surrey County Hospital

    Immunotherapy and Colon Cancer

  • Hanna Preus / PhD, MBA: Speaking at the Oncology Convention

    Hanna Preus / PhD, MBA
    Opiant Pharmaceuticals

    Quality Risk Management of Clinical trials at the site – the importance of cooperation

  • Dr Paul Fenton: Speaking at the Oncology Convention

    Dr Paul Fenton
    University Hospital Southampton NHS Foundation Trust

    Rapid Access Multidisciplinary Palliative Assessment and Radiotherapy Treatment (RAMPART) clinic